Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	226.44	9.24	20.99	55.89	63.83	2.39
Short-Term Investments	41.4	-	22.76	-	-	-
Cash & Short-Term Investments	267.85	9.24	43.76	55.89	63.83	2.39
Cash Growth	1389.45%	-78.89%	-21.71%	-12.44%	2568.39%	-55.09%
Accounts Receivable	0.22	1.17	1.36	1.61	2.01	2.04
Other Receivables	-	0.01	0	0.02	0.03	0.03
Receivables	0.22	1.18	7.47	1.63	2.05	2.08
Inventory	-	-	-	1.4	0.98	0.65
Prepaid Expenses	2.11	1.08	0.44	0.39	0.42	0.37
Other Current Assets	-	5.35	1.54	0.03	0.03	0.03
Total Current Assets	270.17	16.84	53.22	59.33	67.3	5.51
Property, Plant & Equipment	46.23	6.32	0.37	2.49	2.73	2.74
Long-Term Investments	-	0.13	0.15	-	-	-
Goodwill	24.06	24.06	-	-	-	-
Other Intangible Assets	50	50.35	0.03	0.11	0.13	0.14
Other Long-Term Assets	0.69	0.18	4.33	2.52	0.26	0.32
Total Assets	391.15	97.89	58.09	64.44	70.42	8.7
Accounts Payable	21.31	6.11	1.54	0.97	0.73	0.65
Accrued Expenses	3.98	4.39	1.3	1.03	0.82	0.69
Current Portion of Long-Term Debt	0.05	0.05	-	-	-	-
Current Portion of Leases	0.9	0.05	-	0.27	0.25	0.24
Other Current Liabilities	0.5	5.07	0.28	-	-	-
Total Current Liabilities	28.14	15.66	3.12	2.27	1.8	1.58
Long-Term Debt	1.64	1.68	-	-	-	-
Long-Term Leases	1.68	0.78	-	0.26	0.52	0.77
Long-Term Deferred Tax Liabilities	4.59	4.59	-	-	-	-
Other Long-Term Liabilities	0.03	-	0.33	0.64	0.69	0.63
Total Liabilities	62.68	22.71	3.45	3.16	3.01	2.98
Common Stock	0.07	0.28	0.14	0.14	0.14	0.07
Additional Paid-In Capital	519.95	227.34	160.43	159.73	158.59	93.59
Retained Earnings	-191.55	-152.44	-105.93	-98.6	-91.33	-87.94
Total Common Equity	328.47	75.18	54.64	61.28	67.41	5.72
Shareholders' Equity	328.47	75.18	54.64	61.28	67.41	5.72
Total Liabilities & Equity	391.15	97.89	58.09	64.44	70.42	8.7
Total Debt	4.27	2.55	-	0.52	0.78	1.01
Net Cash (Debt)	263.58	6.69	43.76	55.37	63.05	1.39
Net Cash Growth	1695.86%	-84.72%	-20.97%	-12.19%	4445.93%	-73.96%
Net Cash Per Share	4.90	0.25	3.08	3.90	6.07	0.21
Filing Date Shares Outstanding	67.59	58.69	28	14.21	14.19	6.89
Total Common Shares Outstanding	67.56	28.18	14.21	14.2	14.19	6.89
Working Capital	242.03	1.17	50.1	57.06	65.5	3.93
Book Value Per Share	4.86	2.67	3.84	4.31	4.75	0.83
Tangible Book Value	254.41	0.76	54.62	61.17	67.28	5.59
Tangible Book Value Per Share	3.77	0.03	3.84	4.31	4.74	0.81
Land	1.28	1.28	0.37	0.37	0.37	0.37
Buildings	1.77	1.77	-	-	-	-
Machinery	10.6	2.68	0.02	4.44	4.2	3.87
Leasehold Improvements	3.5	0.18	-	4.14	4.14	4.14

Source: S&P Capital IQ. Standard template. Financial Sources.